GFM
AMRX icon

GF Fund Management’s Amneal Pharmaceuticals AMRX Stock Holding History

GF Fund Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$115K Sell
6,656
-404
-6% -$5.54K ﹤0.01% 320
2026
Q1 		$87.8K Buy
7,060
+882
+14% +$11.8K ﹤0.01% 351
2025
Q4 		$77.8K Sell
6,178
-579
-9% -$6.63K ﹤0.01% 366
2025
Q3 		$67.6K Sell
6,757
-1,177
-15% -$10.6K ﹤0.01% 366
2025
Q2 		$64.2K Hold
7,934
– – ﹤0.01% 394
2025
Q1 		$66.5K Buy
7,934
+1,428
+22% +$11.9K ﹤0.01% 395
2024
Q4 		$51.5K Buy
+6,506
New +$54.6K ﹤0.01% 387

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

GF Fund Management's AMRX Position: Q2 2026 in Review

GF Fund Management reduced its Amneal Pharmaceuticals (AMRX) stake by 5.7% in Q2 2026, selling an estimated $5.54K and leaving 6,656 shares worth $115K. The position accounts for ﹤0.01% of the portfolio, ranked #320.

GF Fund Management first reported a position in AMRX in Q4 2024 and has held it in 7 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • GF Fund Management held 6,656 shares of Amneal Pharmaceuticals worth $115K as of Q2 2026.
  • GF Fund Management sold 404 Amneal Pharmaceuticals shares in Q2 2026, an estimated $5.54K.
  • Amneal Pharmaceuticals made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #320 holding.
  • GF Fund Management first reported a position in Amneal Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.